MIVACRON 20mg / 10ml solution for injection / infusion medication leaflet

M03AC10 mivacuriu • Musculo-skeletal system | Muscle relaxants, peripherally acting agents | Other quaternary ammonium compounds

Mivacurium is a neuromuscular blocking agent used for muscle relaxation during surgical procedures or tracheal intubation. It works by blocking nicotinic receptors at the neuromuscular junction, preventing muscle contraction.

The medication is administered via intravenous injection, and its effect is short-lasting, making it suitable for short-duration procedures. Common side effects include hypotension, skin rashes, and bronchospasm.

Mivacurium is contraindicated in patients with hypersensitivity to the active substance or plasma cholinesterase deficiency. Its use also requires careful monitoring of respiratory function and blood pressure.

This medication is an effective option for muscle relaxation in surgical settings, helping to facilitate complex medical procedures.

General data about MIVACRON 20mg / 10ml

Substance: mivacuriu

Date of last drug list: 01-10-2024

Commercial code: W64307001

Concentration: 20mg / 10ml

Pharmaceutical form: solution for injection / infusion

Packing volume: 10 ml

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: GLAXOSMITHKLINE MANUFACTURING S.P.A. - ITALIA

Holder: ASPEN PHARMA TRADING LIMITED - IRLANDA

Number: 2317/2010/01

Shelf life: 18 months

Pharmaceutical forms available for mivacuriu

Concentrations available for mivacuriu

10mg/5ml, 20mg/10ml, 2mg/ml